1. Home
  2. NSP vs PHAT Comparison

NSP vs PHAT Comparison

Compare NSP & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$26.50

Market Cap

819.5M

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$10.58

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
PHAT
Founded
1986
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
819.5M
894.0M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
NSP
PHAT
Price
$26.50
$10.58
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$47.67
$19.50
AVG Volume (30 Days)
1.1M
940.4K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
8.95%
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
$6,812,000,000.00
$175,110,000.00
Revenue This Year
$3.45
$92.15
Revenue Next Year
$6.95
$59.79
P/E Ratio
N/A
N/A
Revenue Growth
3.51
216.93
52 Week Low
$18.57
$2.21
52 Week High
$90.63
$18.31

Technical Indicators

Market Signals
Indicator
NSP
PHAT
Relative Strength Index (RSI) 54.73 43.50
Support Level $18.57 $10.06
Resistance Level $48.91 $12.62
Average True Range (ATR) 1.72 0.67
MACD 1.15 0.08
Stochastic Oscillator 84.65 35.00

Price Performance

Historical Comparison
NSP
PHAT

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: